| __timestamp | Agios Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 5758000 |
| Thursday, January 1, 2015 | 141827000 | 8423000 |
| Friday, January 1, 2016 | 220163000 | 11986000 |
| Sunday, January 1, 2017 | 292681000 | 15215000 |
| Monday, January 1, 2018 | 1397000 | 15356000 |
| Tuesday, January 1, 2019 | 1317000 | 16660000 |
| Wednesday, January 1, 2020 | 2805000 | 52459000 |
| Friday, January 1, 2021 | 18777000 | 75061000 |
| Saturday, January 1, 2022 | 1704000 | 87221000 |
| Sunday, January 1, 2023 | 9504000 | 83779000 |
| Monday, January 1, 2024 | 4165000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, understanding cost structures is pivotal. Over the past decade, Supernus Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. have showcased intriguing trends in their cost of revenue. From 2014 to 2023, Agios Pharmaceuticals experienced a dramatic 90% decline in costs, peaking in 2017 and then plummeting by 2022. In contrast, Supernus Pharmaceuticals saw a steady rise, with costs increasing by over 1,400% from 2014 to 2023. This divergence highlights the strategic shifts within these companies, reflecting broader industry trends. While Agios streamlined operations post-2017, Supernus expanded its cost base, possibly indicating growth or increased production. These insights offer a window into the financial strategies shaping the pharmaceutical sector, underscoring the importance of cost management in maintaining competitive advantage.
Analyzing Cost of Revenue: AstraZeneca PLC and Supernus Pharmaceuticals, Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Agios Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Biogen Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Incyte Corporation vs Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Xenon Pharmaceuticals Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down MorphoSys AG and Supernus Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Bausch Health Companies Inc. and Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Supernus Pharmaceuticals, Inc. and Evotec SE
Cost of Revenue: Key Insights for Supernus Pharmaceuticals, Inc. and MiMedx Group, Inc.
Cost of Revenue Comparison: Agios Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.